KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Medical Sciences / 2016 / Cilt: 46 - Sayı: 5

Chronic liver diseases and iron: a concise review with emphasis on hypotransferrinemia and hypohepcidinemia

Naciye Şemnur BÜYÜKAŞIK
Yahya BÜYÜKAŞIK
Sayfa
1281–1291
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this review, we aimed to present a general outlook of this extensively studied topic.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Abstract: Iron studies in chronic liver diseases (CLDs) have a long history.
📊
Temel Bulgular & Veri:Currently we can mention certainties, uncertainties, and hopes related to this topic.
💡
Sonuç & Katkı:In this review, we aimed to present a general outlook of this extensively studied topic.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Abstract: Iron studies in chronic liver diseases (CLDs) have a long history. Currently we can mention certainties, uncertainties, and hopes related to this topic. It is certain that iron metabolism problems and hepatic siderosis are frequent in CLDs and they get more frequent as CLD progresses, but true iron overload is rare. There are conflicting literature data on the mechanism of siderosis, the role of iron in CLD pathogenesis, and the potential benefits of iron removal. We may hope that pharmacological approaches targeting iron metabolism disorders of CLD will be actively evaluated in the future. In this review, we aimed to present a general outlook of this extensively studied topic.

🔖

Bu Makaleye Atıf Yap

BÜYÜKAŞIK, N. Ş., BÜYÜKAŞIK, Y. (2022). Chronic liver diseases and iron: a concise review with emphasis on hypotransferrinemia and hypohepcidinemia. Turkish Journal of Medical Sciences, Cilt: 46 - Sayı: 5, 1281–1291. https://ajindex.com/articles/610798

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Beaumont C, Vaulont S. Iron homeostasis. In: Beaumont C, Beris P, Beuzard Y, Brugnara C, editors. Disorders of Iron Homeostasis, Erythrocytes, Erythropoiesis. Paris, France: European School of Haematology; 2006. pp. 392-406
  2. Fleming RE, Sly WS. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. P Natl Acad Sci USA 2001; 98: 8160- 8162
  3. Batts KP. Iron overload syndromes and the liver. Mod Pathol 2007; 20 (Suppl.): S31-39
  4. Riva A, Trombini P, Mariani R, Salvioni A, Coletti S, Bonfadini S, Paolini V, Pozzi M, Facchetti R, Bovo G et al. Revaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome. World J Gastroenterol 2008; 14: 4745- 4752
  5. Turlin B, Mendler MH, Moirand R, Guyader D, Guillygomarch A, Deugnier Y. Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients. Am J Clin Pathol 2001;116: 263-270
  6. Mendler MH, Turlin B, Moirand R, Jouanolle AM, Sapey T, Guyader D, Le Gall JY, Brissot P, David V, Deugnier Y. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999; 117: 1155-1163
  7. Herbut PA, Tamaki HT. Cirrhosis of the liver and diabetes as related to hemochromatosis. Am J Clin Pathol 1946; 16: 640- 650
  8. MacDonald RA. Idiopathic hemochromatosis. A variant of portal cirrhosis and idiopathic hemosiderosis. Arch Intern Med 1961; 107: 606-616
  9. Zimmerman HJ, Chomet B, Kulesh MH, McWhorter CA. Hepatic hemosiderin deposits. Incidence in 558 biopsies from patients with and without intrinsic hepatic disease. Arch Intern Med 1961; 107: 494-503
  10. Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WP. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997; 112: 882-888
  11. Barry M, Cartei G, Sherlock S. Measurement of iron stores in cirrhosis using diethylenetriamine penta-acetic acid. Gut 1970; 11: 899-904
  12. Callender ST, Malpas JS. Absorption of iron in cirrhosis of liver. Br Med J 1963; 2: 1516-1518
  13. Friedman BI, Schaefer JW, Schiff L. Increased iron-59 absorption in patients with hepatic cirrhosis. J Nucl Med 1966; 7: 594-602
  14. Golberg L, Smith JP. Iron overloading and hepatic vulnerability. Am J Pathol 1960; 36: 125-149
  15. Schwartz SO. Exogenous hemochromatosis; concept and general description. Am J Clin Pathol 1956; 26: 744-749
  16. Krause A, Neitz S, Mägert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K. LEAP-1